Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suzanne M K Buckley

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Therapeutic Delivery|July 25, 2012
Perinatal gene delivery to the CNSAhad A Rahim, Suzanne M K Buckley, Jerry K Y Chan, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 1, 2012
Choice of surrogate and physiological markers for prenatal gene therapyJuliette M K M Delhove, Ahad A Rahim, Tristan R McKay, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 1, 2012
Animal models for prenatal gene therapy: rodent models for prenatal gene therapyJessica L Roybal, Masayuki Endo, Suzanne M K Buckley, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 27, 2005
In utero gene therapy: current challenges and perspectivesSimon N Waddington, M Gabriela Kramer, Ruben Hernandez-Alcoceba, et al.
Journal of Virology|June 8, 2007
Targeting of adenovirus serotype 5 (Ad5) and 5/47 pseudotyped vectors in vivo: fundamental involvement of coagulation factors and redundancy of CAR binding by Ad5Simon N Waddington, Alan L Parker, Menzo Havenga, et al.
Therapeutic Delivery|July 25, 2012
Recent advances in fetal gene therapySuzanne M K Buckley, Ahad A Rahim, Jerry K Y Chan, et al.
Current Pharmaceutical Design|July 22, 2011
Perinatal gene transfer to the liverTristan R McKay, Ahad A Rahim, Suzanne M K Buckley, et al.
Journal of Immunology Research|March 12, 2015
Evidence for contribution of CD4+ CD25+ regulatory T cells in maintaining immune tolerance to human factor IX following perinatal adenovirus vector deliveryMegha S Nivsarkar, Suzanne M K Buckley, Alan L Parker, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 5, 2008
Intra-amniotic delivery of CFTR-expressing adenovirus does not reverse cystic fibrosis phenotype in inbred CFTR-knockout miceSuzanne M K Buckley, S N Waddington, S Jezzard, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 26, 2010
Gene delivery of a mutant TGFβ3 reduces markers of scar tissue formation after cutaneous woundingSimon N Waddington, Rachel Crossley, Vicky Sheard, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Therapeutic Delivery|July 25, 2012
Perinatal gene delivery to the CNSAhad A Rahim, Suzanne M K Buckley, Jerry K Y Chan, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 1, 2012
Choice of surrogate and physiological markers for prenatal gene therapyJuliette M K M Delhove, Ahad A Rahim, Tristan R McKay, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 1, 2012
Animal models for prenatal gene therapy: rodent models for prenatal gene therapyJessica L Roybal, Masayuki Endo, Suzanne M K Buckley, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 27, 2005
In utero gene therapy: current challenges and perspectivesSimon N Waddington, M Gabriela Kramer, Ruben Hernandez-Alcoceba, et al.
Journal of Virology|June 8, 2007
Targeting of adenovirus serotype 5 (Ad5) and 5/47 pseudotyped vectors in vivo: fundamental involvement of coagulation factors and redundancy of CAR binding by Ad5Simon N Waddington, Alan L Parker, Menzo Havenga, et al.
Therapeutic Delivery|July 25, 2012
Recent advances in fetal gene therapySuzanne M K Buckley, Ahad A Rahim, Jerry K Y Chan, et al.
Current Pharmaceutical Design|July 22, 2011
Perinatal gene transfer to the liverTristan R McKay, Ahad A Rahim, Suzanne M K Buckley, et al.
Journal of Immunology Research|March 12, 2015
Evidence for contribution of CD4+ CD25+ regulatory T cells in maintaining immune tolerance to human factor IX following perinatal adenovirus vector deliveryMegha S Nivsarkar, Suzanne M K Buckley, Alan L Parker, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 5, 2008
Intra-amniotic delivery of CFTR-expressing adenovirus does not reverse cystic fibrosis phenotype in inbred CFTR-knockout miceSuzanne M K Buckley, S N Waddington, S Jezzard, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 26, 2010
Gene delivery of a mutant TGFβ3 reduces markers of scar tissue formation after cutaneous woundingSimon N Waddington, Rachel Crossley, Vicky Sheard, et al.
Pageof 4